NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.6800
-0.0280 (-3.95%)
Feb 20, 2026, 4:00 PM EST - Market closed

NMTC Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
344431212747
Market Cap Growth
13.77%45.65%43.23%-22.25%-42.21%66.31%
Enterprise Value
313729181739
Last Close Price
0.680.890.990.891.693.95
PS Ratio
2.933.678.836.2512.92195.11
PB Ratio
5.356.2837.113.412.857.23
P/TBV Ratio
5.406.3240.423.462.897.38
EV/Sales Ratio
2.653.038.455.418.23159.21
Debt / Equity Ratio
0.040.040.320.030.020.05
Net Debt / Equity Ratio
-0.52-0.89-1.46-0.82-1.14-1.00
Net Debt / EBITDA Ratio
0.451.590.100.441.100.65
Net Debt / FCF Ratio
0.532.160.110.391.400.76
Asset Turnover
1.561.500.510.330.200.04
Inventory Turnover
5.083.683.416.9412.88-
Quick Ratio
4.953.400.742.973.615.88
Current Ratio
6.414.442.094.083.936.17
Return on Equity (ROE)
-146.27%-91.34%-348.39%-149.61%-123.77%-230.81%
Return on Assets (ROA)
-63.40%-32.70%-110.33%-71.43%-60.39%-100.59%
Return on Capital Employed (ROCE)
-104.50%-49.80%-376.60%-189.60%-103.20%-151.20%
Earnings Yield
-19.87%-8.12%-40.38%-55.68%-36.50%-20.99%
FCF Yield
-18.22%-6.57%-36.49%-62.31%-28.46%-18.29%
Buyback Yield / Dilution
-58.14%-50.03%-47.69%-13.27%-49.56%-97.52%
Updated Feb 17, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q